The changing dynamics of pharma outsourcing in Asia

The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and companies need to set their strategic sights on a future world. This new report from PricewaterhouseCoopers highlights the dramatic change and development in pharmaceutical outsourcing in Asia.

The report, The changing dynamics of pharma outsourcing in Asia, covers three significant developments; the trend towards high end innovation, rapid expansion of clinical trials in Asia, and a scaling up of pharma manufacturing in Asia.

Key highlights

• Moving up the value chain and expansion of clinical trials
• Overview of Asian regions by three key dimensions - cost, risk and market opportunity
• Strategic context of outsourcing and location decision in Asia.

To download The changing dynamics of pharma outsourcing in Asia [PDF 1.3 MB] please submit the following form.

Name
Job title
Organisation
Email

Information submitted by this form will only be used in accordance with the PwC Privacy Policy.